1. Persistent remodeling and neurodegeneration in late-stage retinal degeneration
- Author
-
Bryan W. Jones, Rebecca L. Pfeiffer, and Robert E. Marc
- Subjects
0301 basic medicine ,Retinal degeneration ,Degeneration (medical) ,Vascular Remodeling ,Retina ,Article ,Photoreceptor cell ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Retinitis pigmentosa ,medicine ,Animals ,Humans ,Cell Death ,business.industry ,Retinal Degeneration ,Neurodegeneration ,Retinal Vessels ,Neurodegenerative Diseases ,Retinal ,Macular degeneration ,medicine.disease ,Sensory Systems ,Ophthalmology ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,Disease Progression ,030221 ophthalmology & optometry ,business ,Neuroscience ,Retinal Neurons - Abstract
Retinal remodeling is a progressive series of negative plasticity revisions that arise from retinal degeneration, and are seen in retinitis pigmentosa, age-related macular degeneration and other forms of retinal disease. These processes occur regardless of the precipitating event leading to degeneration. Retinal remodeling then culminates in a late-stage neurodegeneration that is indistinguishable from progressive central nervous system (CNS) proteinopathies. Following long-term deafferentation from photoreceptor cell death in humans, and long-lived animal models of retinal degeneration, most retinal neurons reprogram, then die. Glial cells reprogram into multiple anomalous metabolic phenotypes. At the same time, survivor neurons display degenerative inclusions that appear identical to progressive CNS neurodegenerative disease, and contain aberrant α-synuclein (α-syn) and phosphorylated α-syn. In addition, ultrastructural analysis indicates a novel potential mechanism for misfolded protein transfer that may explain how proteinopathies spread. While neurodegeneration poses a barrier to prospective retinal interventions that target primary photoreceptor loss, understanding the progression and time-course of retinal remodeling will be essential for the establishment of windows of therapeutic intervention and appropriate tuning and design of interventions. Finally, the development of protein aggregates and widespread neurodegeneration in numerous retinal degenerative diseases positions the retina as a ideal platform for the study of proteinopathies, and mechanisms of neurodegeneration that drive devastating CNS diseases.
- Published
- 2020